Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.76, 2013, Pages

  Kayser, Cristiane ^a   Sekiyama, Juliana Y ^a   Próspero, Lucas C ^a   Camargo, Cintia Z ^a   Andrade, Luís E C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Capillaroscopy; Mortality; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; AVASCULAR SCORE; BLOOD VESSEL PARAMETERS; CAPILLAROSCOPY; DISEASE SEVERITY; FEMALE; FORCED VITAL CAPACITY; GENDER; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MORTALITY; MULTIVARIATE ANALYSIS; NAILFOLD CAPILLAROSCOPY; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL PREDICTION; SURVIVAL RATE; SYSTEMIC SCLEROSIS; UNIVARIATE ANALYSIS; ANGIOSCOPY; FOLLOW UP; KAPLAN MEIER METHOD; MIDDLE AGED; NAIL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; RISK FACTOR; VASCULARIZATION; VITAL CAPACITY;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NAILS; PREDICTIVE VALUE OF TESTS; RAYNAUD DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; VITAL CAPACITY;

EID: 84883764649     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ASSASSI S, Del JUNCO D, SUTTER K et al.: Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 2009; 61: 1403-11.
2. FERRI C, VALENTINI G, COZZI F, et al.: Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81: 139-53.
3. MEDSGER TA Jr, MASI AT, RODNAN GP, BENEDEK TG, ROBINSON H: Survival with systemic sclerosis (scleroderma): a life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971; 75: 369-76.
4. STEEN VD, MEDSGER TA: Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4.
5. BRYAN C, HOWARD Y, BRENNAN P, BLACK C, SILMAN A: Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 1996; 35: 1122-6.
6. IOANNIDIS JPA, VLACHOYIANNOPOULOS PG, HAIDICH AB, et al.: Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118: 2-10.
7. ABU-SHAKRA M, LEE P: Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol 1995; 22: 2100-2.
8. MAYES MD, LACEY JV Jr, BEEBE-DIMMER J, et al.: Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246-55.
9. ANDRADE LEC, GABRIEL JRA, ASSAD RL, FERRARI JAL, ATRA E: Panoramic nailfold cappilaroscopy: a new reading method and normal range. Semin Arthritis Rheum 1990; 20: 21-31.
10. MARICQ KR, LEROY EC, D'ANGELO WA, et al.: Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23: 183-9.
11. HUDSON M, MASETTO A, STEELE R, ARTHURS E, BARON M, Canadian Scleroderma Research Group: Reliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosis. Clin Exp Rheumatol 2010; 28 (Suppl. 62): 36-41.
12. SULLI A, SECCHI ME, PIZZORNI C, CUTOLO M: Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008; 67: 885-7.
13. CARAMASCHI P, CANESTRINI S, MARTINELLI N, et al.: Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology 2007; 46: 1566-9.
14. SATO LT, KAYSER C, ANDRADE LE: Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients. Acta Reumatol Port 2009; 34: 219-27.
15. SCUSSEL-LONZETTI L, JOYAL F, RAYNAULD JP, et al.: Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002; 81: 154-67.
16. SIMEÓN CP, ARMADANS L, FONOLLOSA V, et al.: Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 2003; 42: 71-5.
17. Subcommittee for sc leroderma criteria of the American Rheumatism Ass ociation Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
18. LEROY EC, BLACK C, FLEISCHMAJER R, et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
19. LEE P, LEUNG FY, ALDERDICE C, ARMSTRONG SK: Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assesment. J Rheumatol 1983; 10: 930-8.
20. ANTON JM, CASTRO P, ESPINOSA G, et al.: Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study. Clin Exp Rheumatol 2012; 30: 338-44.
21. ELHAI M, MEUNE C, AVOUAC J, KAHAN A, ALLANORE Y: Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology 2012; 51: 1017-26.
22. MARICQ HR, SPENCER-GEEN G, LEROY EC: Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976; 61: 862-70.
23. SEKIYAMA JY, CAMARGO CZ, ANDRADE LEC, KAYSER C: Comparison of wide-field nailfold capillaroscopy and videocapillaroscopy in the assessment of the microcirculation in patients with Raynaud's phenomenon [abstract]. Arthritis Rheum 2011; 63: S570.
24. JOYAL F, CHOQUETTE D, ROUSSIN A, LEVINGTON C, SENÉCAL JL: Evaluation of the severity of systemic sclerosis by nailfold capillary microscopy in 112 patients. Angiology 1992; 43: 203-10.
25. BREDEMEIER M, XAVIER RM, CAPOBIANCO KG, et al.: Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004; 31: 286-94.
26. Al-DHAHER FF, POPE JE, OUIMET JM: Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 2010; 39: 269-77.
27. MATHAI SC, HUMMERS LK, CHAMPION HC, et al.: Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 2009; 60: 569-77.
28. SILMAN AJ: Scleroderma: demographics and survival. J Rheumatol 1997; 48 (Suppl.): 58- 61.
29. AVOUAC J, FRANSEN J, WALKER UA, et al.: Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011; 70: 476-81.
30. SPENCER-GREEN G: Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998; 158: 595-600.
31. HERRICK AL, CUTOLO M: Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 2010; 2: 2595-604.